Desitin Arzneimittel GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Desitin Arzneimittel GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10930
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Desitin Arzneimittel GmbH (Desitin) formerly Desitin Compagnie mbH, is a specialty pharmaceutical company which develops and produces products for the treatment of central nervous system (CNS) related neurological and psychiatric diseases. Its product portfolio includes antiepileptic drugs and antiparkinson medication. It offers medicines for illnesses such as Parkinson’s disease, epilepsy, dystonia, actinic keratosis, and post-stroke spasticity. Desitin also provides active pharmaceutical ingredients (APIs), besides manufacturing, clinical development, regulatory support, market access and health care services. It markets and distributes its products through a network of partner companies across Europe. The company has operations with offices in Denmark, Sweden, Norway, Czech Republic, Slovakia, Romania, Switzerland and the UK. Desitin is headquartered in Hamburg, Germany.

Desitin Arzneimittel GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Desitin Arzneimittel Enters Into Co-Promotion Agreement With GlaxoSmithKline For Elontril 10
Biofrontera Enters Into Co-Marketing Agreement With Desitin For Ameluz 11
Licensing Agreements 12
Pozen Enters Into Licensing Agreement With Desitin Arzneimittel For MT 400 12
Advicenne Pharma Enters into Licensing Agreement with Desitin 13
Desitin Arzneimittel GmbH – Key Competitors 14
Desitin Arzneimittel GmbH – Key Employees 15
Desitin Arzneimittel GmbH – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Desitin Arzneimittel GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Desitin Arzneimittel Enters Into Co-Promotion Agreement With GlaxoSmithKline For Elontril 10
Biofrontera Enters Into Co-Marketing Agreement With Desitin For Ameluz 11
Pozen Enters Into Licensing Agreement With Desitin Arzneimittel For MT 400 12
Advicenne Pharma Enters into Licensing Agreement with Desitin 13
Desitin Arzneimittel GmbH, Key Competitors 14
Desitin Arzneimittel GmbH, Key Employees 15
Desitin Arzneimittel GmbH, Subsidiaries 16

List of Figures
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Desitin Arzneimittel GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Desitin Arzneimittel GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Norfolk Southern Corp (NSC):企業の財務・戦略的SWOT分析
    Norfolk Southern Corp (NSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Molex LLC-医療機器分野:企業M&A・提携分析
    Summary Molex LLC (Molex), a subsidiary of Koch Industries, is a US-based manufacturer of electronic components. The company principally focuses on manufacturing and sale of electronic, electrical and fiber optic interconnection systems. Molex's product portfolio includes switches, integrated produc …
  • SK Innovation Co., Ltd.:企業の戦略・SWOT・財務情報
    SK Innovation Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Innovation Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Corning Incorporated:企業の戦略・SWOT・財務情報
    Corning Incorporated - Strategy, SWOT and Corporate Finance Report Summary Corning Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Toyota Tsusho Corporation (8015):企業の財務・戦略的SWOT分析
    Toyota Tsusho Corporation (8015) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Kaneka Corp (4118):企業の財務・戦略的SWOT分析
    Kaneka Corp (4118) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Burmeister & Wain Scandinavian Contractor AS:企業の戦略的SWOT分析
    Burmeister & Wain Scandinavian Contractor AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Islami Bank Bangladesh Ltd:企業の戦略・SWOT・財務分析
    Islami Bank Bangladesh Ltd - Strategy, SWOT and Corporate Finance Report Summary Islami Bank Bangladesh Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • The Tokyo Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    The Tokyo Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Tokyo Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, ope …
  • Fidelity Investments Inc:企業の戦略・SWOT・財務情報
    Fidelity Investments Inc - Strategy, SWOT and Corporate Finance Report Summary Fidelity Investments Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Gradalis Inc-製薬・医療分野:企業M&A・提携分析
    Summary Gradalis Inc (Gradalis), formerly Murex Pharmaceuticals, is a biopharmaceutical company which focuses on the development and commercialization of therapies for the treatment of cancer. Its developmental pipeline comprises of candidates for various cancer indications which include ovarian, br …
  • Sensorion SA (ALSEN):企業の財務・戦略的SWOT分析
    Summary Sensorion SA (Sensorion) is a biopharmaceutical company that develops therapies. The company provides treatments for vestibular and cochlear pathologies. It develops drug candidates through its technology platform for the treatment of various therapeutic areas including vestibular neuritis, …
  • Nestle USA, Inc.:企業の戦略・SWOT・財務情報
    Nestle USA, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nestle USA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Alphatec Holdings Inc (ATEC)-医療機器分野:企業M&A・提携分析
    Summary Alphatec Holdings Inc (Alphatec) is a medical technology company that carries out the design, development, manufacturing and marketing of implants for the surgical treatment of spine disorders. Its major products include anterior cervical plate system, posterior cervico/thoracic fixation sys …
  • J D Wetherspoon plc:企業の戦略・SWOT・財務分析
    J D Wetherspoon plc - Strategy, SWOT and Corporate Finance Report Summary J D Wetherspoon plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Liechtensteinische Landesbank Ag
    Liechtensteinische Landesbank Ag - Strategy, SWOT and Corporate Finance Report Summary Liechtensteinische Landesbank Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Astra Microwave Products Limited:企業の戦略・SWOT・財務分析
    Astra Microwave Products Limited - Strategy, SWOT and Corporate Finance Report Summary Astra Microwave Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Biotest AG (BIO):製薬・医療:M&Aディール及び事業提携情報
    Summary Biotest AG (Biotest) provides pharmaceutical and biotherapeutic drugs. It develops, manufactures and distributes biological medicines through its value chain from preclinical and clinical development to sales. Its main products comprise clotting factors, immunoglobulins, albumin and monoclon …
  • Atomenergoprom:企業の戦略的SWOT分析
    Atomenergoprom - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Pharmascience Inc-製薬・医療分野:企業M&A・提携分析
    Summary Pharmascience Inc (Pharmascience) is a pharmaceutical company that develops, manufactures and markets medicinal products. The company offers generic, prescription, over-the-counter and private label OTC products. It offers drugs in therapeutic areas of anti-inflammatory, cancer, cardiovascul …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆